Advances in Anatomic Pathology

Papers
(The TQCC of Advances in Anatomic Pathology is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
The Social Media Paradox: Unravelling the Impact of Digital Networks on Pathology49
Controversial and Evolving Issues in Gynecologic Pathology39
Do We Have Sufficient Evidence to Define Prognosis for “Low-grade” Fumarate Hydratase–deficient Renal Cell Carcinoma?37
The Many Faces of Serous Neoplasms and Related Lesions of the Female Pelvis: A Review37
SWI/SNF-deficient Sinonasal Carcinomas28
Update on the Use of Molecular Subtyping in Breast Cancer26
Artificial Intelligence and Lung Pathology24
Role of Surgical Pathologist for the Detection of Immuno-oncologic Predictive Factors in Non-small Cell Lung Cancers23
Invasive Squamous Cell Carcinoma of the Cervix: A Review of Morphological Appearances Encountered in Human Papillomavirus-associated and Papillomavirus-independent Tumors and Precursor Lesions21
Molecular Subtypes of Bladder Cancer: Component Signatures and Potential Value in Clinical Decision-making20
Mesothelioma: A Tumor of Ubiquitous Distribution18
Rare Liver Diseases With Near-Normal Histology: A Review Focusing on Metabolic, Storage, and Inclusion Disorders18
Selected Case From the Arkadi M. Rywlin International Pathology Slide Seminar: Involvement of Skin and Soft Tissue by Erdheim-Chester Disease16
Uterine Smooth Muscle Tumors: An Overview15
The Significance of Recognition of Human Epidermal Growth Factor 2 Low in Breast Cancer Therapy15
The “Other” Uterine Mesenchymal Neoplasms: Recent Developments and Emerging Entities14
Mesonephric-like Adenocarcinoma of the Female Genital Tract: From Morphologic Observations to a Well-characterized Carcinoma With Aggressive Clinical Behavior14
#PathX: #PathTwitter’s Transformation and a Discussion on Different Social Media Platforms Used by Pathologists in 202413
Recently Described and Molecularly Defined Head and Neck Tumors13
Mediastinal Pathology13
Follicular Neoplasm of Thyroid Revisited: Current Differential Diagnosis and the Impact of Molecular Testing13
Pathologic Diagnosis of Well-differentiated Hepatocellular Lesions: A Practical Approach to Diagnosis With Particular Focus in Core Needle Biopsies and Utilization of Ancillary Techniques13
The International System for Reporting Serous Fluid Cytopathology: A Systematic Review and Meta-Analysis of Diagnostic Test Accuracy Studies12
Mediastinal Germ Cell Tumors: A Review and Update on Pathologic, Clinical, and Molecular Features12
Diagnostic Approach to Mesenchymal and Spindle Cell Tumors of the Breast11
Papillary Renal Cell Carcinoma: Evolving Classification by Combined Morphologic and Molecular Means11
Sampling and Reporting of Inflammatory Bowel Disease11
A Pattern-based Pathology Approach to Very Early-onset Inflammatory Bowel Disease: Thinking Beyond Crohn Disease and Ulcerative Colitis10
Advances in Adrenal and Extra-adrenal Paraganglioma: Practical Synopsis for Pathologists10
Malignant Mesothelioma of Tunica Vaginalis Testis: Update for 20229
Amyloid Arthropathy: A Review9
Lipomatous Neoplasms of Soft Tissue: A Contemporary Review9
DNA Damage Response and Mismatch Repair Gene Defects in Advanced and Metastatic Prostate Cancer9
The Diagnostic Spectrum of Myelodysplastic Syndromes and Acute Myeloid Leukemia9
Grossing, Staging, and Reporting—An Integrated Manual of Modern Surgical Pathology8
Mesotheliomas in Children8
Diagnostic Approach to Myeloproliferative Neoplasms and Myelodysplastic/Myeloproliferative Neoplasms8
The Classic, the Trendy, and the Refashioned: A Primer for Pathologists on What Is New in Familial Endocrine Tumor Syndromes8
Response to the Letter to the Editor Entitled “Do We Have Sufficient Evidence to Define Prognosis for ‘Low-grade’ Fumarate Hydratase-deficient Renal Cell Carcinoma?”7
Preneoplastic and Neoplastic Biliary Diseases7
Pathology of Surgically Resected Lung Cancers Following Neoadjuvant Therapy7
#PathMastodon: An Up-In-Coming Platform for Pathology Education Among Pathologists, Trainees, and Medical Students7
Special Issue on Neuroendocrine Tumors: Updates on Classification Systems, Streamlining Diagnosis, and Emphasis on Molecular Signatures in Neuroendocrine Neoplasms6
An Overview of Pituitary Neuroendocrine Tumors (PitNET) and Algorithmic Approach to Diagnosis6
Cartilage Forming Tumors of the Skeleton5
Approach to FNA of Myxoid Soft Tissue Tumors5
TRPS1, a New Promising Marker for Assessment of Distant Metastatic Breast Cancer5
Immune-Checkpoint-Inhibitor Therapy—Principles and Relevance of Biomarkers for Pathologists and Oncologists5
Gastrointestinal and Hepatobiliary Immune-related Adverse Events: A Histopathologic Review5
Giant Cell-Rich Tumors of the Skeleton4
Pediatric Mesenchymal Tumors4
Common Diagnostic Challenges in Genitourinary Mesenchymal Tumors: A Practical Approach4
Approach to FNA of Pancreatic Cysts4
Updates on Urinary Bladder Tumors With Neuroendocrine Features4
Mesenchymal Tumors of the Human Body: A Targeted Practical Review4
Update on Selected High-grade Renal Cell Carcinomas of the Kidney: FH-deficient, ALK-rearranged, and Medullary Carcinomas4
Low-grade Oncocytic Fumarate Hydratase-deficient Renal Cell Carcinoma: An Update on Biologic Potential, Morphologic Spectrum, and Differential Diagnosis With Other Low-grade Oncocytic Tumors4
0.088733911514282